Cargando…

Extracellular Vesicles as Potential Therapeutic Messengers in Cancer Management

SIMPLE SUMMARY: Extracellular vesicles (EVs) are vehicles of cell communication that are able to carry several types of biomolecules derived from parent cells which, in a cancer context, can represent an oncogenic behavior, delivering them to recipient cells. Additionally, EVs present advantageous f...

Descripción completa

Detalles Bibliográficos
Autores principales: Almeida, Cristina, Teixeira, Ana Luísa, Dias, Francisca, Morais, Mariana, Medeiros, Rui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10215130/
https://www.ncbi.nlm.nih.gov/pubmed/37237479
http://dx.doi.org/10.3390/biology12050665
_version_ 1785047989784412160
author Almeida, Cristina
Teixeira, Ana Luísa
Dias, Francisca
Morais, Mariana
Medeiros, Rui
author_facet Almeida, Cristina
Teixeira, Ana Luísa
Dias, Francisca
Morais, Mariana
Medeiros, Rui
author_sort Almeida, Cristina
collection PubMed
description SIMPLE SUMMARY: Extracellular vesicles (EVs) are vehicles of cell communication that are able to carry several types of biomolecules derived from parent cells which, in a cancer context, can represent an oncogenic behavior, delivering them to recipient cells. Additionally, EVs present advantageous features, namely biocompatibility and high stability, which make them useful as delivery systems of new potential anticancer drugs. In fact, EVs can be used for the delivery of siRNAs, miRNAs, proteins, and nanoparticles in different diseases contexts. In this review, we highlight the potential application of EVs as drug delivery systems and their clinical applications. ABSTRACT: A deeper understanding of the communication mechanisms of tumor cells in a tumor microenvironment can improve the development of new therapeutic solutions, leading to a more personalized approach. Recently, the field of extracellular vesicles (EVs) has drawn attention due to their key role in intercellular communication. EVs are nano-sized lipid bilayer vesicles that are secreted by all types of cells and can function as intermediators of intercellular communication with the ability to transfer different cargo (proteins, nucleic acids, sugar…) types among cells. This role of EVs is essential in a cancer context as it can affect tumor promotion and progression and contribute to the pre-metastatic niche establishment. Therefore, scientists from basic, translational, and clinical research areas are currently researching EVs with great expectations due to their potential to be used as clinical biomarkers, which are useful for disease diagnosis, prognosis, patient follow-up, or even as vehicles for drug delivery due to their natural carrier nature. The application of EVs presents numerous advantages as drug delivery vehicles, namely their capacity to overcome natural barriers, their inherent cell-targeting properties, and their stability in the circulation. In this review, we highlight the distinctive features of EVs, their application as efficient drug delivery systems, and their clinical applications.
format Online
Article
Text
id pubmed-10215130
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-102151302023-05-27 Extracellular Vesicles as Potential Therapeutic Messengers in Cancer Management Almeida, Cristina Teixeira, Ana Luísa Dias, Francisca Morais, Mariana Medeiros, Rui Biology (Basel) Review SIMPLE SUMMARY: Extracellular vesicles (EVs) are vehicles of cell communication that are able to carry several types of biomolecules derived from parent cells which, in a cancer context, can represent an oncogenic behavior, delivering them to recipient cells. Additionally, EVs present advantageous features, namely biocompatibility and high stability, which make them useful as delivery systems of new potential anticancer drugs. In fact, EVs can be used for the delivery of siRNAs, miRNAs, proteins, and nanoparticles in different diseases contexts. In this review, we highlight the potential application of EVs as drug delivery systems and their clinical applications. ABSTRACT: A deeper understanding of the communication mechanisms of tumor cells in a tumor microenvironment can improve the development of new therapeutic solutions, leading to a more personalized approach. Recently, the field of extracellular vesicles (EVs) has drawn attention due to their key role in intercellular communication. EVs are nano-sized lipid bilayer vesicles that are secreted by all types of cells and can function as intermediators of intercellular communication with the ability to transfer different cargo (proteins, nucleic acids, sugar…) types among cells. This role of EVs is essential in a cancer context as it can affect tumor promotion and progression and contribute to the pre-metastatic niche establishment. Therefore, scientists from basic, translational, and clinical research areas are currently researching EVs with great expectations due to their potential to be used as clinical biomarkers, which are useful for disease diagnosis, prognosis, patient follow-up, or even as vehicles for drug delivery due to their natural carrier nature. The application of EVs presents numerous advantages as drug delivery vehicles, namely their capacity to overcome natural barriers, their inherent cell-targeting properties, and their stability in the circulation. In this review, we highlight the distinctive features of EVs, their application as efficient drug delivery systems, and their clinical applications. MDPI 2023-04-27 /pmc/articles/PMC10215130/ /pubmed/37237479 http://dx.doi.org/10.3390/biology12050665 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Almeida, Cristina
Teixeira, Ana Luísa
Dias, Francisca
Morais, Mariana
Medeiros, Rui
Extracellular Vesicles as Potential Therapeutic Messengers in Cancer Management
title Extracellular Vesicles as Potential Therapeutic Messengers in Cancer Management
title_full Extracellular Vesicles as Potential Therapeutic Messengers in Cancer Management
title_fullStr Extracellular Vesicles as Potential Therapeutic Messengers in Cancer Management
title_full_unstemmed Extracellular Vesicles as Potential Therapeutic Messengers in Cancer Management
title_short Extracellular Vesicles as Potential Therapeutic Messengers in Cancer Management
title_sort extracellular vesicles as potential therapeutic messengers in cancer management
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10215130/
https://www.ncbi.nlm.nih.gov/pubmed/37237479
http://dx.doi.org/10.3390/biology12050665
work_keys_str_mv AT almeidacristina extracellularvesiclesaspotentialtherapeuticmessengersincancermanagement
AT teixeiraanaluisa extracellularvesiclesaspotentialtherapeuticmessengersincancermanagement
AT diasfrancisca extracellularvesiclesaspotentialtherapeuticmessengersincancermanagement
AT moraismariana extracellularvesiclesaspotentialtherapeuticmessengersincancermanagement
AT medeirosrui extracellularvesiclesaspotentialtherapeuticmessengersincancermanagement